Creating an effective clinical trial transparency program can be difficult. What should your company consider before developing a transparency strategy? Join Darshan Kulkarni as he talks about how to successfully create a transparency strategy that...
Clinical studies have become increasingly virtual because of COVID-19. How has this affected the way the FDA inspects clinical trials? Join Darshan Kulkarni as he talks with former FDA auditor Patrick Stone about his experience investigating sites...
Clinical study transparency programs are necessary for companies looking to disclose data and fully comply with state and federal regulations. Why else should your company create a transparency program? Join Darshan Kulkarni as he talks with guest...
It can be difficult to set up a clinical research site for the first time. What are some of the most common issues? In today’s episode, Darshan Kulkarni joins clinical research expert Kelly Willenberg to talk about setting up a compliant clinical...
Many ethical concerns are raised after patients die in clinical trials. Once a patient dies, what happens to their consent? Join Darshan Kulkarni as he talks with professor of philosophy Peter Koch about the rights patients have after death. Plus...
It’s important to know the right time to file a trademark. How early should you file? Join Darshan Kulkarni as he talks with trademark lawyer Donna Tobin about the application process when filing for a trademark. Plus, we’ll discuss the key...
